Home
News
Create
Screeners
Insights
Vista Pharmaceuticals
7.
45
+0.16
(+2.19%)
Market Cap
₹45.89 Cr
PE Ratio
-5.83
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+2.19%
1M
+2.19%
6M
-24.37%
1Y
-31.40%
5Y
-42.52%
View Company Insights
Latest news about Vista Pharmaceuticals
Vista Pharmaceuticals Limited Files Quarterly Compliance Certificate for Q4 FY26
Apr 14, 2026
Vista Pharmaceuticals Limited filed its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26 with BSE Limited on 14.04.2026. The certificate confirms proper handling of dematerialization processes, with registrar Aarthi Consultants Private Limited certifying completion of all required actions including certificate mutilation, record substitution, and timeline compliance within the stipulated 15-day period.
Vista Pharmaceuticals Reports Widened Q3 FY26 Loss at ₹231.94 Lakhs Amid Revenue Decline
Feb 13, 2026
Vista Pharmaceuticals Ltd Forms Strategic Joint Venture with Pleiades Therapeutics for Global Drug Development
Feb 03, 2026
Vista Pharmaceuticals Reports Widened Quarterly Loss, Reappoints Key Executives
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO